Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 3/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL28921589 | 1.00 | SLC6A4 (0.48) | SLC6A4SLC6A2SLC6A3KDM1APTPN7 | |
| SCHEMBL23842763 | 0.85 | SLC6A4 (0.60) | SLC6A4SLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL30690927 | 0.83 | SLC6A4 (0.58) | SLC6A4SLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL6964855 | 0.83 | SLC6A4 (0.58) | SLC6A4SLC6A2SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830800 | 0.82 | SLC6A2 (0.45) | SLC6A4SLC6A2SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL21590609 | 0.81 | SLC6A2 (0.49) | SLC6A4SLC6A2SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830859 | 0.80 | SLC6A2 (0.45) | SLC6A4SLC6A2SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL30182604 | 0.80 | ITGB1 (0.41) | SLC6A4SLC6A2SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL19405848 | 0.80 | SLC6A4 (0.54) | SLC6A4SLC6A2SLC6A3MEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL23830840 | 0.78 | SLC6A2 (0.47) | SLC6A4SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292305-A1 | Cyclic Ureas | SIRONAX LTD (KY) | 2021-09-23 | — | — | US | disclosed |
| CN-113302183-A | Cyclic ureas | 圣瑞诺有限公司 | 2021-08-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292305-A1 | Cyclic Ureas | RIPK1, RIPK3, RIPK4 | SLC6A4 4608/4885SLC6A2 4844/4885SLC6A3 4703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.